| Dr Hany S Shenouda, MD | |
|
101 S Ravenel St Ste 300, Florence, SC 29506-2621 | |
| (843) 777-7490 | |
| (843) 777-7480 |
| Full Name | Dr Hany S Shenouda |
|---|---|
| Gender | Male |
| Speciality | Endocrinology |
| Experience | 48 Years |
| Location | 101 S Ravenel St Ste 300, Florence, South Carolina |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1346232246 | NPI | - | NPPES |
| 5901654 | Medicaid | NC | |
| 266567100 | Medicaid | FL | |
| 3104132 | Medicaid | NH | |
| 1346232246 | Medicaid | NC | |
| N01349 | Medicaid | SC |
| Facility Name | Location | Facility Type |
|---|---|---|
| Thedacare Regional Med Ctr - Neenah | Neenah, WI | Hospital |
| Thedacare Medical Center-waupaca | Waupaca, WI | Hospital |
| Thedacare Regional Medical Center - Appleton Inc | Appleton, WI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Thedacare Incorporated | 1759294887 | 493 |
News Archive
Arisaph Pharmaceuticals, Inc. announced today during an oral presentation at the American Heart Association (AHA) meeting in Los Angeles, CA that its niacin analog, ARI-3037MO, was extremely well tolerated in a single-ascending dose (SAD) and a multiple-ascending dose (MAD) trial in healthy male and female volunteers.
Teva Pharmaceutical Industries, Ltd. today announced the U.S. Food and Drug Administration (FDA) approved the newly revised prescribing information for AZILECT® (rasagiline tablets) reducing medication and food restrictions.
Drinking straws are single use plastic products which will be subjected to a Europe-wide sales ban from 2021 onwards. This is stated in EU Directive 2019/904 from 5 June 2019.
A new study by researchers in the U.S. further supports the hypothesis that the unregulated release of inflammatory cytokines is responsible for the local and systemic inflammation that is associated with multi-organ damage and death in severe COVID-19.
› Verified 2 days ago
| Entity Name | Thedacare Incorporated |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376656959 PECOS PAC ID: 1759294887 Enrollment ID: O20031106000088 |
News Archive
Arisaph Pharmaceuticals, Inc. announced today during an oral presentation at the American Heart Association (AHA) meeting in Los Angeles, CA that its niacin analog, ARI-3037MO, was extremely well tolerated in a single-ascending dose (SAD) and a multiple-ascending dose (MAD) trial in healthy male and female volunteers.
Teva Pharmaceutical Industries, Ltd. today announced the U.S. Food and Drug Administration (FDA) approved the newly revised prescribing information for AZILECT® (rasagiline tablets) reducing medication and food restrictions.
Drinking straws are single use plastic products which will be subjected to a Europe-wide sales ban from 2021 onwards. This is stated in EU Directive 2019/904 from 5 June 2019.
A new study by researchers in the U.S. further supports the hypothesis that the unregulated release of inflammatory cytokines is responsible for the local and systemic inflammation that is associated with multi-organ damage and death in severe COVID-19.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Hany S Shenouda, MD 101 S Ravenel St Ste 300, Florence, SC 29506-2621 Ph: (843) 777-7490 | Dr Hany S Shenouda, MD 101 S Ravenel St Ste 300, Florence, SC 29506-2621 Ph: (843) 777-7490 |
News Archive
Arisaph Pharmaceuticals, Inc. announced today during an oral presentation at the American Heart Association (AHA) meeting in Los Angeles, CA that its niacin analog, ARI-3037MO, was extremely well tolerated in a single-ascending dose (SAD) and a multiple-ascending dose (MAD) trial in healthy male and female volunteers.
Teva Pharmaceutical Industries, Ltd. today announced the U.S. Food and Drug Administration (FDA) approved the newly revised prescribing information for AZILECT® (rasagiline tablets) reducing medication and food restrictions.
Drinking straws are single use plastic products which will be subjected to a Europe-wide sales ban from 2021 onwards. This is stated in EU Directive 2019/904 from 5 June 2019.
A new study by researchers in the U.S. further supports the hypothesis that the unregulated release of inflammatory cytokines is responsible for the local and systemic inflammation that is associated with multi-organ damage and death in severe COVID-19.
› Verified 2 days ago
Dr. Brian Thomas Trezak, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 805 Pamplico Hwy, Florence, SC 29505 Phone: 843-792-1414 | |
Dr. Harry S. Allen Ii Iii, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 214 W Pine St., Florence, SC 29501 Phone: 843-661-0500 Fax: 843-661-7370 | |
Carolyn Reynolds, MD Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: 555 E Cheves St, Florence, SC 29506 Phone: 843-777-2314 Fax: 843-777-5035 | |
Brinda Rakesh Chokshi, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 360 N Irby St, Florence, SC 29501 Phone: 843-667-9414 Fax: 843-667-1362 | |
Francisco Xavier Barrera Echegoyen, Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: 360 N Irby St, Florence, SC 29501 Phone: 843-667-9414 Fax: 843-667-1362 | |
Dr. Ifeanyichukwu Madubobi Eruchalu, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 401 E Cheves St, Suite 202, Florence, SC 29506 Phone: 843-777-7863 Fax: 843-777-7873 | |
Prabal K. Guha, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 101 William H. Johnson Street, Suite 600, Florence, SC 29506 Phone: 843-667-1891 Fax: 843-665-2516 |